Our goal is to accelerate the best ideas in Parkinson's disease research toward clinical testing and practical relevance for patients. By placing a strong emphasis on translational and clinical research, we ensure that new ideas are constantly flowing into the drug development pipeline.
Sitting at the nexus of Parkinson's research worldwide, we are constantly building and refining our understanding of the therapeutic needs of Parkinson's patients. Our research agenda is crafted around these needs, reflecting two key areas:
Through our annual Pipeline Strategy, we constantly seek new ideas, relevant biological targets and promising therapeutics that can benefit people with Parkinson's disease. In addition, our team of experts looks for challenge areas where the Foundation's proactive effort can accelerate the development of new and improved treatments. Priority areas allow the Foundation to quickly deploy resources and expertise where it is needed most.